• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1808060
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Sepsis (2067); Osteomyelitis (4533)
Event Date 01/09/2022
Event Type  Injury  
Event Description
It was reported through litigation process that seven months seven days post a port placement, the patient allegedly developed with bacteremia, sepsis and osteomyelitis.It was further reported that the infected port was removed.However, the current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately seven months and six days post port placement, patient presented to the emergency room with epistaxis that has been persistent over the last day.He also developed increased shortness of breath and started having fevers as high after admission.Around one day later, patient had an infectious disease consultation for bacteremia in immunocompromised host.His blood cultures are now growing mssa.Ct chest shows evidence of haziness in the right sternoclavicular angle that seems to be nonspecific but possibility of septic joint or osteomyelitis is not completely excluded.He was diagnosed with sepsis, mssa bacteremia, port infection, possible sternoclavicular osteomyelitis/septic arthritis, chronic lymphocytic leukemia and epistaxis.He was on cefepime and strongly recommended discontinuation of port followed by repeat blood culture.High grade bacteremia with staphylococcus aureus.Around one day later patient underwent removal of right chest port and catheter, irrigation and debridement of right chest wound soft tissue and packing of open right chest wound.The tip of catheter sent to microbiology for culture/stain of afb, fungal, aerobic and anaerobic bacteria.Around eleven days later, patient status improved and discharged to home.Around two months and twenty-one days later, patient presented for ongoing infections in the port area.He has been taking antibiotics off and on in outpatient.Mri of the chest showed concern for osteomyelitis of the surrounding bone.Cultures were drawn and he was started on broad spectrum antibiotic.Around two months and nine days later, patient underwent debridement of sternoclavicular joint infection with partial resection of manubrium and partial resection of the clavicle.Therefore, the investigation is inconclusive for the reported adverse event as no objective evidence was provided for review.Furthermore, the clinical conditions alleged in the complaint cannot be confirmed.Based on the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 06/2022).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18928360
MDR Text Key337944439
Report Number3006260740-2024-01152
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027031
UDI-Public(01)00801741027031
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1808060
Device Lot NumberREEZ1827
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexMale
-
-